<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230416057919N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-11-06</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Exercise therapy in low back pain</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of Adding Motor Skill Retraining Versus Adding Balance Training to a Standard Core Stabilization Program on Pain and Function in Adults With Chronic Non-Radicular Low Back Pain: Randomized Controlled Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-05-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/94589</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants will be randomized using a permuted block randomization method with a block size of four and a 1:1 allocation ratio to maintain a balanced number of participants between the two groups throughout the recruitment process. For this purpose, all possible allocation sequences within blocks of four (AABB, ABAB, ABBA, BAAB, BABA, BBAA) will be generated. In these sequences, A represents the core stability exercise group combined with motor skill retraining, and B represents the core stability exercise group combined with balance exercises. The order of the blocks will then be determined randomly using a random number table or computer software. Eligible participants will be allocated to one of the two groups according to their order of enrollment in the study and the predefined allocation sequence. This randomization method will help maintain numerical balance between the two groups and reduce selection bias throughout the study. The assigned intervention will be documented in the randomization record form and kept confidential in the research file, Blinding description: Since the types of exercises differ between the two groups, blinding the therapist is not feasible. However, the outcome assessor (responsible for conducting functional tests, recording questionnaires, and performing ultrasound measurements) will be kept blinded to group allocation as much as possible. For this purpose, assessment sessions will be conducted separately from exercise sessions by an individual who is not involved in administering the exercises or laser treatment. Participants will be instructed not to disclose details of the exercises they received in the presence of the assessor. This approach will help reduce assessor bias and improve the internal validity of the study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Non radicular low back pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Motor skill retraining. Intervention 2: Intervention group: Balance training.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No further information is available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ahmad Nazari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran, Sattar Khan St., Niayesh St., corner of Mansouri St., Hazrat Rasool Akram Hospital</address>
        <city>tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1449614535</zip>
        <telephone>+98 21 6435 2446</telephone>
        <email>Nazari.a@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ahmad Nazari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran, Sattar Khan St., Niayesh St., corner of Mansouri St., Hazrat Rasool Akram Hospital</address>
        <city>tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1449614535</zip>
        <telephone>+98 21 6435 2446</telephone>
        <email>Nazari.a@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of non-radicular low back pain by a sports medicine specialist, based on clinical examination and the absence of clear signs of nerve root involvement (radiating pain along a dermatomal distribution, focal muscle weakness, diminished reflexes, or localized neurological deficits).
Duration of pain ≥ 3 months (chronic low back pain) or recurrent episodes of low back pain over the past ≥ 6 months.
Low back pain intensity of at least 3 out of 10 on the Visual Analog Scale (VAS) during the preceding week.
Ability to walk independently and perform the prescribed exercises.
Provision of written informed consent.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Presence of red flags or indications for urgent imaging, including trauma associated with a risk of fracture, fever or suspected infection, known or suspected malignancy, cauda equina syndrome, unexplained weight loss, high-risk osteoporosis, progressive spinal deformity, or progressive neurological deficits.
Clinical evidence of radiculopathy or nerve root involvement, including dermatomal radiating pain extending below the knee and reproduced by the Straight Leg Raise (SLR) or Slump test; myotomal weakness, dermatomal sensory deficits, or diminished reflexes consistent with a specific nerve root; or a positive Crossed Straight Leg Raise test.
Recent spinal surgery within the past 12 months, being scheduled for surgical intervention during the study period, or receiving epidural or spinal injections within the past 6 months.
Other significant neurological, vestibular, or musculoskeletal disorders that substantially impair balance or functional performance.
Pregnancy.
Participation in another active rehabilitation program for low back pain within the past 3 months.
Regular use of strong opioid medications or major changes in the analgesic medication regimen within the past 4 weeks.
Presence of evidence of severe spinal canal stenosis or disc sequestration on lumbar magnetic resonance imaging (MRI).
Unwillingness to continue participation in the study.
Absence from more than 20% of the scheduled exercise sessions.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Low back pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Motor skill retraining</i_keyword>
      <i_keyword>Intervention group: Balance training</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: Before the intervention, and at weeks 4 and 8 after the initiation of the intervention. Method of measurement: Visual Analogue Scale.</prim_outcome>
      <prim_outcome>Disability level. Timepoint: Before the intervention, and at weeks 4 and 8 after the initiation of the intervention. Method of measurement: Oswestry Disability Index (ODI).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Biering–Sorensen Test. Timepoint: Before the intervention, and at weeks 4 and 8 after the initiation of the intervention. Method of measurement: The Sorensen test will be used to assess lumbar extensor muscle endurance. Participants will lie prone on an examination table with their anterior superior iliac spines positioned approximately at the edge of the table, allowing the trunk to extend beyond the table without support. The pelvis and lower limbs will be secured using three straps placed around the pelvis, thighs, and ankles. The arms will be crossed over the chest or positioned behind the head, with the selected position maintained consistently throughout all assessments. Participants will be instructed to maintain their trunk in a horizontal position, parallel to the floor. The duration of maintaining this position will be measured using a stopwatch. The test will be terminated when the participant can no longer maintain the horizontal position, the trunk drops more than 10 degrees below horizontal, or pain or fatigue prevents continuation. A brief familiarization trial lasting a maximum of 10 to 15 seconds will be performed before the main test, followed by adequate rest. The final result will be recorded in seconds.</sec_outcome>
      <sec_outcome>Timed Up and Go Test (TUG). Timepoint: Before the intervention, and at weeks 4 and 8 after the initiation of the intervention. Method of measurement: The Timed Up and Go test will be used to assess functional mobility and dynamic balance. Participants will initially sit in a standard armchair with their backs resting against the backrest. A line will be marked on the floor at a distance of three meters from the chair. At the command to start, participants will be instructed to stand up from the chair, walk at their usual comfortable and safe pace to the marked line, turn around, walk back to the chair, and sit down again. The time will be measured using a stopwatch, starting at the verbal command and ending when the participant is fully seated again. Participants will wear their usual footwear and may use their customary walking aid if necessary. A familiarization trial will be performed before the main assessment. The test will then be performed three times, with adequate rest intervals between trials. The shortest completion time among the three trials will be recorded in seconds as the final test result. A shorter completion time indicates better functional mobility performance.</sec_outcome>
      <sec_outcome>Transversus Abdominis (TrA) Muscle Thickness at Rest. Timepoint: Before the intervention, and at weeks 4 and 8 after the initiation of the intervention. Method of measurement: Mean transversus abdominis (TrA) muscle thickness measured by ultrasonography at rest, at the end of quiet expiration.</sec_outcome>
      <sec_outcome>Transversus Abdominis (TrA) Muscle Thickness During Contraction. Timepoint: Before the intervention, and at weeks 4 and 8 after the initiation of the intervention. Method of measurement: Mean transversus abdominis (TrA) muscle thickness measured by ultrasonography during contraction, at the end of quiet expiration.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-05-15</approval_date>
        <contact_name>Ethics Committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Tehran - Sattar Khan St. - Niayesh St. - Hazrat Rasool Akram Hospital (PBUH) Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
